Sign In

James Gilmore

Life Sciences Commercialization Executive

James Gilmore is a business executive with extensive experience in the biotechnology and laboratory services industries. He currently holds several key positions:

Current Roles

  • CEO of LISA (Laboratory Integration Strategic Association)26
  • Co-Founder of BlazedX3
  • Co-Founder of BrainSpores4

Professional Background

James Gilmore has a diverse background in marketing, sales, and business leadership. His career spans multiple companies and roles in the life sciences sector:

  • Previously worked with SeqOnce Biosciences Inc.34
  • Has experience in impactful marketing and sales leadership5

Recent Initiatives

In 2024, Gilmore has been involved in several significant projects:

  • Launched BlazedX, a company dedicated to helping translational research labs get up and running quickly3
  • Led the launch of LISA, an association aimed at supporting CAP and COLA-accredited diagnostic laboratories in navigating new FDA regulatory requirements for Laboratory Developed Tests (LDTs)2

As CEO of LISA, Gilmore is spearheading a collaborative crowdfunding model to develop and submit new assays for FDA clearance. This initiative is designed to help clinical laboratories address challenges posed by evolving FDA regulations while fostering innovation in diagnostic testing.26

LinkedIn Profile

James Gilmore's LinkedIn username is james-gilmore-0b25132, as mentioned in the query. His profile likely contains more detailed information about his professional experiences and accomplishments.5

While not directly related to the James Gilmore in question, it's worth noting that there is another prominent James Gilmore who co-authored "The Experience Economy" and has a background in business consulting and academia.1 This information is provided to avoid any potential confusion between the two individuals.

Highlights

Sep 26 · linkedin

Lyophilization of reagents and assays appears to have a strong impact on ESG and Scope 2/3 emissions! I have been working with Wayne Woodard at Argonaut and Cristina A. to understand the potential reduction in CO2 emissions that lyophilizing reagents and assays can have in our industry as there is not much information publicly available. The strongest CO2e reduction by lyophilization is in transport, through weight savings and removing cold chain requirements. Secondarily, CO2e is reduced in lyophilized assays during longer term storage as they are kept at room temperature. One of the common arguments against lyophilization is that they create more emissions during manufacturing. We took this one on and found that manufacturing of lyophilized reagents created the equivalent CO2e to storing wet reagents for one month. In other words, storing an assay at 4C for one month creates roughly the same amount of CO2e as lyophilizing it, where it is stable for years at room temp and has significant CO2e reduction in transport.

Fun and interesting project- thank you Wayne and Cristina!

Read more here:

https://lnkd.in/gMaEh5kV

Mar 23 · linkedin

Argonaut Manufacturing Services announced immediate availability for production of COVID-19 vaccine and therapeutics. New production line is starting just in time. Great response- great company and team! #covid19 #coronavirusupdate

Related Questions

What is BlazedX's primary focus?
How did James Gilmore get involved with BlazedX?
What other companies has James Gilmore worked with?
What is the mission of the Laboratory Integration Strategic Association (LISA)?
How does BlazedX contribute to LISA's goals?
James Gilmore
James Gilmore, photo 1
James Gilmore, photo 2
Add to my network

Location

Del Mar, California, United States